Library
EmergingMOL · MolecularOROVArboviral surveillance pack
Oropouche virus RNA
Oropouche virus
Last reviewed 2026-08-13
Public health significance
A 2024-2026 expansion that caught many menus flat-footed. This is why a living catalog exists.
Specimen types
Serum, CSF
Method
NAA, commonly LDT
CLIA / validation
LDT validation. Performance characteristics will move as national assays appear.
Interpretation
Detected / Not detected. State clearly that codes and methods are evolving.
Reflex / referral
CDC or regional reference confirmation while assays mature.
Quality control
Positive control from a reference material when available. Document the gap if it is not.
Reportability
Treat as reportable emerging arbovirus. Confirm the current state list.
HL7 / ELR
Use the current LOINC if assigned; otherwise a local code plus method, and update when CDC publishes a mapping.
Sources
CDC Oropouche updates; APHL emerging arbovirus notes.